Immunai raised €18M in a Seed round in May 2020. The company is based in New York, United States. Investors in the round: TLV Partners, Viola Group. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
